N B Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 16-11-2024
- Satisfied Charges ₹ 14.64 Cr
as on 16-11-2024
- Revenue 145.84%
(FY 2023)
- Profit -90.63%
(FY 2023)
- Ebitda -34.71%
(FY 2023)
- Net Worth 2.23%
(FY 2023)
- Total Assets -15.83%
(FY 2023)
About N B Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹14.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Agrawal, Anil Agrawal, and Ved Agrawal serve as directors at the Company.
- CIN/LLPIN
U24295MH1998PTC117004
- Company No.
117004
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does N B Laboratories Private Limited offer?
N B Laboratories Private Limited offers a wide range of products and services, including Ayurvedic Tablets, Spirulina Tablet, Herbal Capsules, Spirulina Capsule, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic,Herbal Products & Medicine, Ayurvedic & Herbal Health Supplement, Herbal Supplements, Barley Grass.
Who are the key members and board of directors at N B Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Agrawal  | Director | 25-May-2023 | Current |
| Rajesh Agrawal | Director | 30-Sep-2004 | Current |
| Ved Agrawal | Director | 02-Oct-2020 | Current |
Financial Performance of N B Laboratories.
N B Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 145.84% increase. The company also saw a substantial fall in profitability, with a 90.63% decrease in profit. The company's net worth moved up by a moderate rise of 2.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of N B Laboratories?
In 2023, N B Laboratories had a promoter holding of 99.20% and a public holding of 0.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ankit Pulps And Boards Private LimitedActive 36 years 2 monthsRajesh Agrawal and Anil Agrawal are mutual person
- T.V.I. Marketing Solutions Private LimitedActive 14 years 8 months
Rajesh Agrawal and Anil Agrawal are mutual person
Sanil Engineers Private LimitedActive 36 years 10 monthsRajesh Agrawal and Anil Agrawal are mutual person
- Poorved Foundation For Social InnovationActive 1 year 3 months
Rajesh Agrawal, Anil Agrawal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 16 Dec 2021 | ₹1.50 Cr | Open |
Punjab National Bank Creation Date: 26 Oct 2013 | ₹11.20 Cr | Satisfied |
Punjab National Bank Creation Date: 25 Sep 2012 | ₹2.56 Cr | Satisfied |
How Many Employees Work at N B Laboratories?
N B Laboratories has a workforce of 29 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of N B Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped N B Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
